Cases 21 - 30 of 1,745
MCNALL v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv21327
Plaintiff:
MARK MCNALL
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES, LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Allergan USA, Inc., et al. v. MSN Laboratories Private Limited, et al.
as 1:2019cv01727
Counter Defendant:
Allergan USA, Inc., Allergan Holdings Unlimited Company and Eden Biodesign, LLC
Counter Claimant:
MSN Laboratories Private Limited, Alkem Laboratories Limited, Hetero USA Inc. and others
Plaintiff:
Eden Biodesign, LLC.
Defendant:
Sun Pharmaceutical Industries Limited, Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
IVERS v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2023cv21150
Plaintiff:
ANTHONY IVERS
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., ARROW PHARM (MALTA) LTD., TEVA PHARMACEUTICAL INDUSTRIES, LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Louisiana Health Service & Indemnity Company et al v. Celgene Corporation et al
as 1:2023cv07871
Plaintiff:
Louisiana Health Service & Indemnity Company individually and on behalf of all others similarly situated doing business as Blue Cross and Blue Shield of Louisiana and HMO Louisiana, Inc.
Defendant:
Celgene Corporation, Bristol Myers Squibb Company, Aurobindo Pharma Limited and others
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation (Monopolizing Trade)
BYARS v. Boehringer Ingelheim Corp. et al
as 9:2023cv80063
Plaintiff:
KIMBERLY BYARS
Defendant:
Boehringer Ingelheim Corp., Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corp. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Kaplan et al v. GlaxoSmithKline LLC et al
as 3:2023cv17678
Plaintiff:
Kenneth Kaplan and Tamara Kaplan
Defendant:
GlaxoSmithKline LLC, GlaxoSmithKline PLC, GlaxoSmithKline (America) Inc. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
BEAMON v. Boehringer Ingelheim Corp. et al
as 9:2023cv80056
Plaintiff:
VELMA BEAMON
Defendant:
Boehringer Ingelheim Corp., Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corp. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Bracero v. Glaxosmithkline, Inc. et al
as 9:2023cv80057
Plaintiff:
Edwin Bracero
Defendant:
Glaxosmithkline, Inc., GlaxoSmithKline LLC, Ajanta Pharma USA Inc. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALITIES LTD. et al
as 1:2023cv06667
Plaintiff:
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant:
EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Counter Claimant:
LUPIN INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
BROCK v. Boehringer Ingelheim Corp. et al
as 9:2023cv80059
Plaintiff:
DORIS BROCK
Defendant:
Boehringer Ingelheim Corp., Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corp. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
